TITLE

ACTION OF L--TYROSINE AND ARACHIDONIC ACID ON EXPERIMENTAL ARTERIAL HYPERTENSION IN THE RAT. PHYSIOLOGICAL AND PATHOGENIC DEDUCTIONS

AUTHOR(S)
Laborit, H.; Vallette, N.
PUB. DATE
May 1976
SOURCE
Angiology;May1976, Vol. 27 Issue 5, p293
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Studies the physiologic action of L-tyrosine and arachidonic acid on experimental arterial hypertension in rat models by researchers from Paris, France. Indications showing a corrective action of L-tyrosine administered intraperitoneally or orally in respect of chronic experimental hypertension; Assessment on the hypotensive effect induced by the compound; Role of the decrease in the central catecholaminergic activity on the aggravation of the experimental hypertension in the rat.
ACCESSION #
16353369

 

Related Articles

  • THE USE OF A NEW DIURETIC (POLYTHIAZIDE) IN CONGESTIVE FAILURE AND HYPERTENSION. Stein, Isidore; Katabi, Ghazi // Angiology;May1962, Vol. 13 Issue 5, p212 

    The article presents a discussion related to the use of a new diuretic polythiazide in congestive failure and hypertension. A. series of patients was studied to observe the effect of a new thiazide on their signs of congestive failure and another group with hypertension. Of 17 patients with...

  • Design of a Genetically Modified Soybean Protein Preventing Hypertension Based on an Anti-Hypertensive Peptide Derived from Ovalbumin. Matoba, N.; Yamada, Y.; Yoshikawa, M. // Current Medicinal Chemistry - Cardiovascular & Hematological Age;Jun2003, Vol. 1 Issue 2, p197 

    Food proteins can be a source of various bioactive peptides including such possessing anti-hypertensive activity. While most orally active anti-hypertensive peptides derived from food proteins inhibit the angiotensin Iconverting enzyme (ACE), ovokinin (2-7) (RADHPF), a peptide isolated from a...

  • Effect of Captopril on Plasma Prolactin in Patients with Essential Hypertension. Saito, Ikuo; Takeshita, Eiko; Hayashi, Satomi; Takenaka, Tunec; Murakami, Marohito; Saruta, Takao; Nagano, Shiro; Sekihara, Toshio // Angiology;May1990, Vol. 41 Issue 5, p377 

    The effects of the angiotensin-converting enzyme inhibitor captopril on blood pressure, heart rate, plasma prolactin, and renin activity were examined in a single-blind, placebo-controlled trial on 30 patients with essential hypertension (15 given drug, 15 placebo). Captopril, 25 mg administered...

  • New combination.  // Formulary;Dec2009, Vol. 44 Issue 12, p355 

    The article reports that a combination of Telmisartan, an angiotensin II receptor blocker (ARB) and amiodipine, a dihydropyridine calcium channel blocker (DHP-CCB) tablets have been approved for hypertension treatment. It states that it can be given alone or in combination with other...

  • The Appropriate Goals of Antihypertensive Therapy: Neither Too Much Nor Too Little. Kaplan, Norman M. // Annals of Internal Medicine;4/15/92, Vol. 116 Issue 8, p686 

    Discusses the management of hypertensive patients. Reasons for undertreatment of hypertension; Reasons for overtreatment of the disease; Problems encountered with antihypertensive drugs.

  • Hypertension and Counter-Hypertension Mechanisms in Giraffes. Qiong Gus Zhang // Cardiovascular & Haematological Disorders - Drug Targets;Mar2006, Vol. 6 Issue 1, p63 

    The giraffe is unique as its head is 2500-3000 millimeters above its heart, thus the giraffe's heart must pump hard enough to overcome the huge hydrostatic pressure generated by the tall column of blood in its neck in order to provide its head with sufficient nutrients and oxygen. Giraffes...

  • Patients noncompliant with cardio meds within six months.  // Pharmaceutical Representative;Aug2005, Vol. 35 Issue 8, p11 

    Examines the ability of patients suffering from high blood pressure or high lipid levels to adherence to a drug regimen including both antihypertensive and lipid-lowering medications. Evaluation of adherence to concomitant therapy; Decrease in the percentage of patients adhering from both...

  • Relationship between the Frequency of Blood Pressure Self-Measurement and Blood Pressure Reduction with Antihypertensive Therapy: Results of the OLMETEL (OLMEsartan TELemonitoring Blood Pressure) Study. Ewald, Silke; vor dem Esche, Johannes; Uen, Sakir; Neikes, Fabian; Vetter, Hans; Mengden, Thomas // Clinical Drug Investigation;2006, Vol. 26 Issue 8, p439 

    OBJECTIVES: This subanalysis of the OLMETEL (OLMEsartan TELemonitoring blood pressure) study in patients with essential hypertension assessed the relationship between the frequency of blood pressure self-measurement (BPSM) and the response to blood pressure (BP)-lowering therapy with olmesartan...

  • Safety and Tolerability of Moxonidine in the Treatment of Hypertension. Schachter, M.; Luszick, J.; Jäger, B.; Verboom, C.; Söhlke, E. // Drug Safety;Sep1998, Vol. 19 Issue 3, p191 

    Classical centrally acting antihypertensive agents lower blood pressure by reducing excessive sympathetic tone; however, their clinical use is limited by an adverse effect profile resulting from α-adrenoceptor agonism. Moxonidine is a new centrally acting agent showing selective agonism of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics